Startseite UR
Publikationen von 0000-0002-7384-2052
(ORCID: 0000-0002-7384-2052)
 | Eine Stufe nach oben |
Anzahl der Einträge: 16.
2015
Hahne, Jens C., Kurz, Antje, Meyer, Susanne R., Dietl, Johannes, Engel, Jörg B. 
und Honig, Arnd
(2015)
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer.
Archives of Gynecology and Obstetrics 291 (1), S. 131-141.
Volltext nicht vorhanden.
und Honig, Arnd
(2015)
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer.
Archives of Gynecology and Obstetrics 291 (1), S. 131-141.
Volltext nicht vorhanden.
May, Matthias, Aziz, Atiqullah, Brookman-May, Sabine, Roghmann, Florian, Noldus, Joachim, Rink, Michael, Chun, Felix , Fisch, Margit, Novotny, Vladimir, Wirth, Manfred, Mayr, Roman, Pycha, Armin, Brisuda, Antonin , Volkmer, Björn, Stredele, Regina, Dechet, Christopher, Vallo, Stefan, Haferkamp, Axel, Schnabel, Marco, Denzinger, Stefan, Roigas, Jan, Stief, Christian G., Gilfrich, Christian , Bastian, Patrick J., Engel, Jörg B. , Burger, Maximilian und Fritsche, Hans-Martin
(2015)
Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.
World Journal of Urology 33 (3), S. 343-350.
Volltext nicht vorhanden.
, Fisch, Margit, Novotny, Vladimir, Wirth, Manfred, Mayr, Roman, Pycha, Armin, Brisuda, Antonin , Volkmer, Björn, Stredele, Regina, Dechet, Christopher, Vallo, Stefan, Haferkamp, Axel, Schnabel, Marco, Denzinger, Stefan, Roigas, Jan, Stief, Christian G., Gilfrich, Christian , Bastian, Patrick J., Engel, Jörg B. , Burger, Maximilian und Fritsche, Hans-Martin
(2015)
Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.
World Journal of Urology 33 (3), S. 343-350.
Volltext nicht vorhanden.
Kwok, C. W., Treeck, O., Buchholz, S., Seitz, S., Ortmann, O. und Engel, J. B.
(2015)
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).
Targeted Oncology 10 (3), S. 365-373.
Volltext nicht vorhanden.
(2015)
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).
Targeted Oncology 10 (3), S. 365-373.
Volltext nicht vorhanden.
2014
Engel, Jörg B. , Honig, Arnd, Kapp, Michaela, Hahne, Jens C., Meyer, Susanne R., Dietl, Johannes und Segerer, Sabine E.
(2014)
Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1.
Archives of Gynecology and Obstetrics 289 (1), S. 141-147.
Volltext nicht vorhanden.
, Honig, Arnd, Kapp, Michaela, Hahne, Jens C., Meyer, Susanne R., Dietl, Johannes und Segerer, Sabine E.
(2014)
Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1.
Archives of Gynecology and Obstetrics 289 (1), S. 141-147.
Volltext nicht vorhanden.
Seitz, Stephan, Buchholz, Stefan, Schally, Andrew Victor, Weber, Florian, Klinkhammer-Schalke, Monika, Inwald, Elisabeth C, Perez, Roberto, Rick, Ferenc G, Szalontay, Luca, Hohla, Florian, Segerer, Sabine, Kwok, Chui Wai, Ortmann, Olaf und Engel, Jörg Bernhard
(2014)
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
BMC Cancer 14 (1).
Volltext nicht vorhanden.
(2014)
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
BMC Cancer 14 (1).
Volltext nicht vorhanden.
2013
Hahne, Jens C., Schmidt, Heike, Meyer, Susanne R., Engel, Jörg B. , Dietl, Johannes und Honig, Arnd
(2013)
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS 126 in models of triple-negative breast cancer.
Journal of Cancer Research and Clinical Oncology 139 (6), S. 905-914.
Volltext nicht vorhanden.
, Dietl, Johannes und Honig, Arnd
(2013)
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS 126 in models of triple-negative breast cancer.
Journal of Cancer Research and Clinical Oncology 139 (6), S. 905-914.
Volltext nicht vorhanden.
SEITZ, S., RICK, F.G. , SCHALLY, A.V. , TRESZL, A., HOHLA, F., SZALONTAY, L., ZARANDI, M., ORTMANN, O., ENGEL, J.B. und BUCHHOLZ, S.
(2013)
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Oncology Reports 30 (1), S. 413-418.
Volltext nicht vorhanden.
, SCHALLY, A.V. , TRESZL, A., HOHLA, F., SZALONTAY, L., ZARANDI, M., ORTMANN, O., ENGEL, J.B. und BUCHHOLZ, S.
(2013)
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Oncology Reports 30 (1), S. 413-418.
Volltext nicht vorhanden.
Hahne, Jens C., Meyer, Susanne R., Gambaryan, Stepan , Walter, Ulrich , Dietl, Johannes, Engel, Jörg B. und Honig, Arnd
(2013)
Immune escape of AKT overexpressing ovarian cancer cells.
International Journal of Oncology 42 (5), S. 1630-1635.
Volltext nicht vorhanden.
, Walter, Ulrich , Dietl, Johannes, Engel, Jörg B. und Honig, Arnd
(2013)
Immune escape of AKT overexpressing ovarian cancer cells.
International Journal of Oncology 42 (5), S. 1630-1635.
Volltext nicht vorhanden.
2012
Engel, J. B. , Seipelt, I., Hönig, A., Hahne, J. C. und Teifel, M.
(2012)
AEZS-131- ein hochselektiver ERK-Inhibitor: Charakterisierung und präklinische Testung im tripelnegativen Mammakarzinom (TNBC).
Geburtshilfe und Frauenheilkunde 72 (07).
Volltext nicht vorhanden.
, Seipelt, I., Hönig, A., Hahne, J. C. und Teifel, M.
(2012)
AEZS-131- ein hochselektiver ERK-Inhibitor: Charakterisierung und präklinische Testung im tripelnegativen Mammakarzinom (TNBC).
Geburtshilfe und Frauenheilkunde 72 (07).
Volltext nicht vorhanden.
Hahne, J. C., Honig, A., Meyer, S. R., Gambaryan, S. , Walter, U. , Wischhusen, J., Häussler, S. F. M., Segerer, S. E., Fujita, N., Dietl, J. und Engel, J. B.
(2012)
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
Oncology Reports 28 (6), S. 2023-2028.
Volltext nicht vorhanden.
, Walter, U. , Wischhusen, J., Häussler, S. F. M., Segerer, S. E., Fujita, N., Dietl, J. und Engel, J. B.
(2012)
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
Oncology Reports 28 (6), S. 2023-2028.
Volltext nicht vorhanden.
Engel, J. B. , Schally, A. V. , Buchholz, S., Seitz, S., Emons, G. und Ortmann, O.
(2012)
Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).
Archives of Gynecology and Obstetrics 286 (2), S. 437-442.
Volltext nicht vorhanden.
, Schally, A. V. , Buchholz, S., Seitz, S., Emons, G. und Ortmann, O.
(2012)
Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).
Archives of Gynecology and Obstetrics 286 (2), S. 437-442.
Volltext nicht vorhanden.
2009
Köster, Frank, Engel, Jörg B. , Schally, Andrew V. , Hönig, Arnd, Schröer, Andreas, Seitz, Stephan, Hohla, Florian, Ortmann, Olaf, Diedrich, Klaus und Buchholz, Stefan
(2009)
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Breast Cancer Research and Treatment 116 (2), S. 273-279.
Volltext nicht vorhanden.
, Schally, Andrew V. , Hönig, Arnd, Schröer, Andreas, Seitz, Stephan, Hohla, Florian, Ortmann, Olaf, Diedrich, Klaus und Buchholz, Stefan
(2009)
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Breast Cancer Research and Treatment 116 (2), S. 273-279.
Volltext nicht vorhanden.
Köster, , make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference , make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference
(2009)
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist Cetrorelix with growth inhibition.
International Journal of Oncology 35 (4).
Volltext nicht vorhanden.
, make_name_string expected hash reference , make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference
(2009)
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist Cetrorelix with growth inhibition.
International Journal of Oncology 35 (4).
Volltext nicht vorhanden.
2007
Buchholz, Stefan, Schally, Andrew V. , Engel, Jörg B. , Hohla, Florian, Heinrich, Elmar, Koester, Frank, Varga, Jozsef L. und Halmos, Gabor
(2007)
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Proceedings of the National Academy of Sciences 104 (6), S. 1943-1946.
Volltext nicht vorhanden.
, Engel, Jörg B. , Hohla, Florian, Heinrich, Elmar, Koester, Frank, Varga, Jozsef L. und Halmos, Gabor
(2007)
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Proceedings of the National Academy of Sciences 104 (6), S. 1943-1946.
Volltext nicht vorhanden.
2006
Buchholz, Stefan, Keller, Gunhild, Schally, Andrew V. , Halmos, Gabor, Hohla, Florian, Heinrich, Elmar, Koester, Frank, Baker, Benjamin und Engel, Jörg B.
(2006)
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.
Proceedings of the National Academy of Sciences 103 (27), S. 10403-10407.
Volltext nicht vorhanden.
, Halmos, Gabor, Hohla, Florian, Heinrich, Elmar, Koester, Frank, Baker, Benjamin und Engel, Jörg B.
(2006)
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.
Proceedings of the National Academy of Sciences 103 (27), S. 10403-10407.
Volltext nicht vorhanden.
1994
Schally, , make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference
(1994)
Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
Oncology Reports.
Volltext nicht vorhanden.
, make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference
(1994)
Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
Oncology Reports.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707